Consolidated Balance Sheets (USD $)	Sep. 30, 2013	Dec. 31, 2012
Current assets:
Cash and cash equivalents	$ 1,736,530	$ 19,032,392
Marketable securities	16,420,483
Accounts receivable (less allowance for doubtful accounts)	859,738	100,769
Inventory	17,398,888
Assets held for sale	3,933,373
Other current assets	727,836	20,859
Total current assets	41,076,848	19,154,020
Property, plant and equipment, net of accumulated depreciation	22,634,371	1,514
Goodwill	1,475,871
Other assets	302,552
Total assets	65,489,642	19,155,534
Current liabilities:
Accounts payable - trade	8,260,861	409,643
Accounts payable - related party	80,328	416,670
Line of credit payable	10,341,257	22,653
Deferred revenue	3,905,875	60,548
Current portion of long-term debt	1,498,828
Other current liabilities	4,014,855	18,375
Total current liabilities	28,102,004	927,889
Long-term debt	27,519,875	20,041,644
Other long-term liabilities	388,350
Total liabilities	56,010,229	20,969,533
Stockholders' equity (deficit):
Preferred stock, par value $0.001 per share, 10,000,000 authorized - 0 - issued and outstanding
Common stock, par value $0.0001 per share, 5,000,000,000 and 490,000,000 shares authorized; 487,712,326 and 487,712,326 shares issued and outstanding, respectively	48,771	48,771
Additional paid-in capital	10,564,260	2,691,942
Accumulated other comprehensive income	223,825
Accumulated deficit	(10,218,701)	(4,554,712)
Total stockholders' equity (deficit) attributable to CVSL	618,155	(1,813,999)
Stockholders' equity attributable to noncontrolling interest	8,861,258
Total stockholders' equity (deficit)	9,479,413	(1,813,999)
Total liabilities and stockholders' equity	$ 65,489,642	$ 19,155,534